Resistance to HIV Protease Inhibitors: Mechanisms and Clinical Consequences

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|5|4|321-328

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.5, Iss.4, 2004-08, pp. : 321-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tipranavir overcomes HIV resistance to protease inhibitors

By  

Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Determining and Overcoming Resistance to HIV Protease Inhibitors

By  

Current Drug Targets - Infectious Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 137-152

Bentham Science Publishers

Access to resources Recommend Favorite

Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4039-4053

Bentham Science Publishers

Access to resources Recommend Favorite

Prospects for the Resistance to HIV Protease Inhibitors: Current Drug Design Approaches and Perspectives

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-01 ,pp. : 3077-3090

Bentham Science Publishers

Access to resources Recommend Favorite

Heterocyclic HIV-Protease Inhibitors

By  

Current Medicinal Chemistry, Vol. 20, Iss. 30, 2013-10 ,pp. : 3693-3710

Bentham Science Publishers

Access to resources Recommend Favorite